Ibuprofen
NDC 50844-393, ibuprofen, tablet, film coated, from L.N.K. International, Inc..
- Product NDC
- 50844-393
- Status
- Listed
- Labeler
- L.N.K. International, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA075139
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50844-393 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBUPROFEN200 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50844-393-02 | 50844039302 | 1 BOTTLE, PLASTIC in 1 CARTON (50844-393-02) / 12 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
| 50844-393-06 | 50844039306 | 200 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-393-06) |
| 50844-393-08 | 50844039308 | 1 BOTTLE, PLASTIC in 1 CARTON (50844-393-08) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
| 50844-393-12 | 50844039312 | 1 BOTTLE, PLASTIC in 1 CARTON (50844-393-12) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
| 50844-393-14 | 50844039314 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-393-14) |
| 50844-393-15 | 50844039315 | 1 BOTTLE, PLASTIC in 1 CARTON (50844-393-15) / 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
| 50844-393-16 | 50844039316 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-393-16) |
| 50844-393-20 | 50844039320 | 225 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-393-20) |
| 50844-393-58 | 50844039358 | 750 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-393-58) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50844-393 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50844-393 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50844-393. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.